Ian Carruthers - Bioquell plc Insider

BIQLF -- USA Stock  

USD 6.28  0.88  16.30%

  Director
Sir Ian Carruthers.OBE is an Independent NonExecutive Director of Bioquell PLC., since August 2010. He Joined the Board in August 2010. He is former Chief Executive of the NHS South of England and has extensive experience of the UK and international healthcare systems. He is a Chairman of Portsmouth Hospitals NHS Trust, Chancellor of the University of West of England and Chair of Healthcare UK.
  Director Since 2010      
44 1264 835 835  http://www.bioquellplc.com

Management Efficiency

The company has return on total asset (ROA) of 5.58 % which means that it generated profit of $5.58 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 10.64 % meaning that it generated $10.64 on every $100 dollars invested by stockholders.

Similar Executives

Entity Summary

Bioquell plc designs, manufactures, and supplies bio-decontamination and containment equipment, and related products and services in the United Kingdom and internationally. The company was incorporated in 1925 and is headquartered in Andover, the United Kingdom. Bioquell plc operates under Medical Devices classification in USA and traded on OTC Market. It employs 220 people.Bioquell plc (BIQLF) is traded on OTC Market in USA. It is located in 52 Royce Close and employs 220 people.

Bioquell plc Leadership Team

Ian Johnson, Non-Executive Chairman of the Board
Nigel Keen, Independent Non-Executive Chairman of the Board
Nicholas Adams, Group Chief Executive and Executive Director
Christopher Mills, Non-Executive Director
Anthony Bourne, Independent Non-Executive Director
Georgina Pope, Company Secretary
Michael Roller, Group Finance Director, Director
Ian Carruthers, Independent Non-Executive Director
Simon Constantine, Independent Non-Executive Director

Stock Performance Indicators

Did you try this?

Run Equity Valuation Now
   

Equity Valuation

Check real value of public entities based on technical and fundamental data
All  Next Launch Equity Valuation

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Bioquell plc and U S Bancorp. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.